Amrutanjan Health Care Limited (AMRUTANJAN:NSE) Annual Income Statement ()
AMRUTANJAN:NSE Quarterly Financials ()
Frequently Asked Questions About Amrutanjan Health Care Limited (AMRUTANJAN:NSE) Stock
Amrutanjan Health Care Limited's (AMRUTANJAN:NSE) last reported annual revenue was INR 3.80 Billion.
Amrutanjan Health Care Limited's (AMRUTANJAN:NSE) annual revenue growth rate based on the revenue reported in the past 5 years is : 8.54%
Amrutanjan Health Care Limited's(AMRUTANJAN:NSE) is profitable as of its last reported annual financials.
The net profit margin for Amrutanjan Health Care Limited's(AMRUTANJAN:NSE) from its laster reported year is 11.85%
The return on equity (ROE) for Amrutanjan Health Care Limited's(AMRUTANJAN:NSE) from its last reported annual financials is : 15.53%
The return on assets (ROA) for Amrutanjan Health Care Limited's(AMRUTANJAN:NSE) from its last reported annual financials is : 7.85%
The return on invested capital (ROIC) for Amrutanjan Health Care Limited's(AMRUTANJAN:NSE) from its last reported annual financials is : 8.72%
The Debt to Equity ratio for Amrutanjan Health Care Limited's(AMRUTANJAN:NSE) from its last reported annual financials is : 0.00%
The dividend yield for Amrutanjan Health Care Limited's(AMRUTANJAN:NSE) from its laster reported year is 0.94%
Amrutanjan Health Care Limited's(AMRUTANJAN:NSE) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AMRUTANJAN:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
